000 | 01496 a2200397 4500 | ||
---|---|---|---|
005 | 20250514184458.0 | ||
264 | 0 | _c20040525 | |
008 | 200405s 0 0 eng d | ||
022 | _a0022-202X | ||
024 | 7 |
_a10.1111/j.0022-202X.2003.12602.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRaychaudhuri, Siba P | |
245 | 0 | 0 |
_aK252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model. _h[electronic resource] |
260 |
_bThe Journal of investigative dermatology _cMar 2004 |
||
300 |
_a812-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarbazoles _xtherapeutic use |
650 | 0 | 4 | _aCell Division |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndole Alkaloids |
650 | 0 | 4 |
_aKeratinocytes _xphysiology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 |
_aNerve Growth Factor _xphysiology |
650 | 0 | 4 |
_aNerve Regeneration _xdrug effects |
650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
650 | 0 | 4 |
_aReceptor, Nerve Growth Factor _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptor, trkA _xphysiology |
700 | 1 | _aSanyal, Mrinmoy | |
700 | 1 | _aWeltman, Helena | |
700 | 1 | _aKundu-Raychaudhuri, Smriti | |
773 | 0 |
_tThe Journal of investigative dermatology _gvol. 122 _gno. 3 _gp. 812-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.0022-202X.2003.12602.x _zAvailable from publisher's website |
999 |
_c14799961 _d14799961 |